SP IKT Holdings LLC 13D/13G Filings for Inhibikase Therapeutics, Inc. (IKT)

SP IKT Holdings LLC 13D and 13G filings for Inhibikase Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2024-10-28
5:26 pm
Purchase
2024-10-2113GInhibikase Therapeutics, Inc.
IKT
SP IKT Holdings LLC5,840,000
8.690%
5,840,000increase
(New Position)
Filing